Hepatotoxicity associated with weight loss or sports dietary supplements, including OxyELITE Pro™ — United States, 2013

Drug Testing and Analysis

Volumn 9, Issue 1, 2017, Pages 68-74

  Chatham Stephens, Kevin ^a,b   Taylor, Ethel ^b   Chang, Arthur ^b   Peterson, Amy ^c   Daniel, Johnni ^b   Martin, Colleen ^b   Deuster, Patricia ^d   Noe, Rebecca ^b   Kieszak, Stephanie ^b   Schier, Josh ^b   Klontz, Karl ^e   Lewis, Lauren ^b  

^a EIS officer   (Gabon)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c Armed Forces Health Surveillance Center   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

hepatitis; OxyELITE Pro; Supplement

Indexed keywords

MUSCLE; NUTRITION; SPORTS; VITAMINS;

DATA SYSTEMS; DEPARTMENT OF DEFENCE; DEPARTMENT OF HEALTHS; HEPATITIS; HEPATOTOXICITY; MULTIPLE SOURCE; OXYELITE PRO; POISON CENTERS; SUPPLEMENT; WEIGHT LOSS;

DIETARY SUPPLEMENTS;

ACUTE HEPATITIS; ADULT; ADVERSE OUTCOME; ARTICLE; ASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY SUPPLEMENT; DISEASE SURVEILLANCE; FATIGUE; FEMALE; HOSPITALIZATION; HUMAN; JAUNDICE; LIVER GRAFT; LIVER TOXICITY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNITED STATES; WEIGHT REDUCTION; CHEMICAL AND DRUG INDUCED LIVER INJURY; DRUG EFFECTS; EPIDEMIOLOGY; HEPATITIS; LIVER; MIDDLE AGED; PATHOLOGY; TOXICITY; YOUNG ADULT;

ANABOLIC AGENT; ANTIOBESITY AGENT;

ADULT; ANABOLIC AGENTS; ANTI-OBESITY AGENTS; CHEMICAL AND DRUG INDUCED LIVER INJURY; DIETARY SUPPLEMENTS; FEMALE; HEPATITIS; HOSPITALIZATION; HUMANS; LIVER; MALE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 84994480381     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.2036     Document Type: Article

References (32)

1. R. L. Bailey, J. J. Gahche, C. V. Lentino, J. T. Dwyer, J. S. Engel, P. R. Thomas, J. M. Betz, C. T. Sempos, M. F. Picciano. Dietary supplement use in the United States, 2003–2006. J. Nutr. 2011, 141, 261.
2. H. M. Blanck, M. K. Serdula, C. Gillespie, D. A. Galuska, P. A. Sharpe, J. M. Conway, L. K. Khan, B. E. Ainsworth. Use of Nonprescription Dietary Supplements for Weight Loss Is Common among Americans. J. Am. Diet. Assoc. 2007, 107, 441.
3. J. J. Knapik, R. A. Steelman, S. S. Hoedebecke, E. K. Farina, K. G. Austin, H. R. Lieberman. A systematic review and meta-analysis on the prevalence of dietary supplement use by military personnel. BMC Complement. Altern. Med. 2014, 14, 1.
4. V. J. Navarro. Herbal and dietary supplement hepatotoxicity. Semin. Liver Dis. 2009, 29, 373.
5. V. J. Navarro, H. Barnhart, H. L. Bonkovsky, T. Davern, R. J. Fontana, L. Grant, K. R. Reddy, L. B. Seeff, J. Serrano, A. H. Sherker, A. Stolz, J. Talwalkar, M. Vega, R. Vuppalanchi. Liver injury from herbals and dietary supplements in the US Drug Induced Liver Injury Network. Hepatology. 2014, 60, 1399.
6. R. Teschke, A. Schwarzenboeck, A. Eickhoff, C. Frenzel, A. Wolff, J. Schulze. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin. Drug Saf. 2013, 12, 339.
7. C. Bunchorntavakul, K. R. Reddy. Review article: herbal and dietary supplement hepatotoxicity. Aliment. Pharmacol. Ther. 2013, 37, 3.
8. M. M. Roytman, P. Porzgen, C. L. Lee, L. Huddleston, T. T. Kuo, P. Bryant-Greenwood, L. L. Wong, N. Tsai. Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am. J. Gastroenterol. 2014, 109, 1296.
9. D. I. Johnston, A. Chang, M. Viray, K. Chatham-Stephens, H. He, E. Taylor, L. L. Wong, J. Schier, C. Martin, D. Fabricant, M. Salter, L. Lewis, S. Y. Park. Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ — Hawaii, 2013. Drug Test. Anal. 2016, 8(3-4), 319.
10. J. B. Mowry, D. A. Spyker, L. R. Cantilena, N. Mcmillan, M. Ford. 2013 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual Report. Clin. Toxicol. 2014, 52, 1032.
11. Food and Drug Administration. MedWatch: the FDA safety information and adverse event reporting program. Available at: http://www.fda.gov/Safety/MedWatch/ [14 May 2014].
12. Centers for Disease Control and Prevention. Acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building. Available at: http://emergency.cdc.gov/han/han00356.asp [05 May 2014].
13. S. Park, M. Viray, D. Johnston, E. Taylor, A. Chang, C. Martin, J. Schier, L. Lewis, K. Levri, K. Chatham-Stephens. Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building — May–October 2013. MMWR Morb. Mortal. Wkly Rep. 2013, 62, 1.
14. H. R. Lieberman, T. B. Stavinoha, S. M. McGraw, A. White, L. S. Hadden, B. P. Marriott. Use of dietary supplements among active-duty US Army soldiers. Am. J. Clin. Nutr. 2010, 92, 985.
15. M. V. Rubertone, J. F. Brundage. The Defense Medical Surveillance System and the Department of Defense Serum Repository: Glimpses of the Future of Public Health Surveillance. Am. J. Public Health. 2002, 92, 1900.
16. Food and Drug Administration. Stimulant Potentially Dangerous to Health, FDA Warns. Available at: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm347270.htm [12 January 2016].
17. S. Foley, E. Butlin, W. Shields, B. Lacey. Experience with OxyELITE Pro and acute liver injury in active duty service members. Dig. Dis. Sci. 2014, 59, 3117.
18. K. C. Klontz, H. J. Debeck, P. Leblanc, K. M. Mogen, B. J. Wolpert, J. L. Sabo, M. Salter, S. L. Seelman, S. E. Lance, C. Monahan, D. S. Steigman, K. Gensheimer. The role of adverse event reporting in the FDA response to a multistate outbreak of liver disease associated with a dietary supplement. Public Health Rep. 2015, 130, 526.
19. M. P. Holt, C. Ju. Mechanisms of drug-induced liver injury. AAPS J. 2006, 8, E48.
20. V. J. Navarro, L. B. Seeff. Liver injury induced by herbal complementary and alternative medicine. Clin. Liver Dis. 2013, 17, 715.
21. E. Elinav, G. Pinsker, R. Safadi, O. Pappo, M. Bromberg, E. Anis, L. Keinan-Boker, E. Broide, Z. Ackerman, D. N. Kaluski, B. Lev, D. Shouval. Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. J. Hepatol. 2007, 47, 514.
22. T. L. Fong, K. C. Klontz, A. Canas-Coto, S. J. Casper, F. A. Durazo, T. J. Davern 2nd, P. Hayashi, W. M. Lee, L. B. Seeff. Hepatotoxicity due to Hydroxycut: a case series. Am. J. Gastroenterol. 2010, 105, 1561.
23. M. Adachi, H. Saito, H. Kobayashi, Y. Horie, S. Kato, M. Yoshioka, H. Ishii. Hepatic injury in 12 patients taking the herbal weight loss aids Chaso or Onshido. Ann. Intern. Med. 2003, 139, 488.
24. J. T. Favreau, M. L. Ryu, G. Braunstein, G. Orshansky, S. S. Park, G. L. Coody, L. A. Love, T. L. Fong. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann. Intern. Med. 2002, 136, 590.
25. A. Reuben, D. G. Koch, W. M. Lee. Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010, 52, 2065.
26. K. Humes, N. Jones, R. Ramirez. Overview of race and Hispanic origin: 2010, U.S. Census Bureau, Washington, DC, 2011.
27. J. Kennedy. Herb and supplement use in the US adult population. Clin. Ther. 2005, 27, 1847.
28. R. J. Fontana, P. H. Hayashi, J. Gu, K. R. Reddy, H. Barnhart, P. B. Watkins, J. Serrano, W. M. Lee, N. Chalasani, A. Stolz, T. Davern, J. A. Talwakar. DILIN Network. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. Gastroenterology. 2014, 147, 96.
29. P. S. Leung, L. Rossaro, P. A. Davis, O. Park, A. Tanaka, K. Kikuchi, H. Miyakawa, G. L. Norman, W. Lee, M. E. Gershwin, Acute Liver Failure Study Group. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology. 2007, 46, 1436.
30. Institute of Medicine. Forging a Poison Prevention and Control System, The National Academies Press, Washington, DC, 2004.
31. National Institutes of Health. Severity grading in drug-induced liver injury. Available at: http://livertox.nih.gov/Severity.html [19 June 2014].
32. C. H. Wu, C. C. Wang, J. Kennedy. Changes in herb and dietary supplement use in the US adult population: A comparison of the 2002 and 2007 National Health Interview Surveys. Clin. Ther. 2011, 33, 1749.